ATGen
Company

date founded

General

About Company
ATGen Diagnóstica offers molecular biology, immunodiagnosis, and biotechnological diagnostic services.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2001

Number of employees

Company Type

For Profit

IPO status

Private

Description

With over 15 years of experience, ATGen Diagnóstica specializes in offering innovative and cost-effective solutions for clinical analysis laboratories, blood banks, and biomedical research. They develop and manufacture diagnostic reagents and recombinant proteins, leveraging their highly skilled workforce and strong connections with the academic sector. Their state-of-the-art laboratory and production facilities ensure compliance with strict quality standards, allowing them to distribute their products nationally and export to several countries in Latin America. Additionally, they represent and distribute more than 10 renowned international brands in the field.
Similar Companies
1000
Diagcor Bioscience

Diagcor Bioscience

Diagcor Bioscience is a biotech company specializing in molecular diagnostics and DNA & RNA analysis services.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Hong Kong Island, Hong Kong
Kogen Biotech

Kogen Biotech

Kogen Biotech provides molecular diagnostic kits and medical devices for in vitro diagnosis.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical Device

Location

Seoul, South Korea
JS Biotech

JS Biotech

JS Biotech is a cutting-edge molecular diagnostics firm.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Diagnostics, Medical

Location

Namyangju-si, Gyeonggi-do, South Korea
DNP Biotech

DNP Biotech

DNP Biotech develops molecular diagnostics DNA biomarkers for personalized treatments.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Health Diagnostics

Location

Seoul, South Korea

Financials

Co-Investors

Activity

Recent News
0